Quantitative Medicine Consultant
Independent Consultant Quantitative Medicine
Lansdale, Pennsylvania
Sandra A.G. Visser is an internationally recognized expert in quantitative medicine and drug development, with over two decades of experience in global pharmaceutical companies AstraZeneca, Merck and GSK. She has a proven track record of integrating biomarker data into mathematical models to optimize clinical trial design, inform dose selection, and accelerate drug development across multiple therapeutic areas including oncology, neuroscience, and diabetes. She is known for her pioneering work in model-informed drug discovery and development (MID3), which has had a tangible impact on drug development strategies and regulatory submissions. She received her PhD degree in quantitative pharmacology from Leiden University, The Netherlands. Currently, she serves as an independent consultant in quantitative medicine, providing strategic insights to biotech startups.
Disclosure information not submitted.
Opportunities for Model-Informed Drug Development and Biomarker Strategies in Rare Diseases
Monday, October 21, 2024
9:30 AM – 10:00 AM MT